Non-invasive Pulse Wave Tonometer Market Forecasts

Non-invasive Pulse Wave Tonometer Market Snapshot (2022 to 2032)

The global non-invasive pulse wave tonometer market size is expected to be valued at US$ 104.3 Million in 2022. Blood flow in the body should be proper to maintain health and also reduce the risk of heart and other problems associated with blood flow. As the blood flow starts its journey from the heart and flows through various veins and arteries. Blood is a very good carrier that can carry nutrients and drugs to different parts of the body.

Data Points	Key Statistics
Non-invasive Pulse Wave Tonometer Market Value 2022	US$ 104.3 Million
Non-invasive Pulse Wave Tonometer Market Projected Value (2032)	US$ 194 Million
Non-invasive Pulse Wave Tonometer Market CAGR (2022 to 2032)	5.8%

The non-invasive pulse wave tonometer is a very good device that can help to understand the flow pattern and provide the information so that the proper treatment can be provided. The overall demand for non-invasive pulse wave tonometers is projected to grow at a CAGR of 5.8% between 2022 and 2032, totaling around US$ 194 Million by 2032.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Non-invasive Pulse Wave Tonometer Demand Analysis (2016 to 2021) Vs Market Outlook (2022 to 2032)

From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 4.7%. The proper monitoring of blood flow helps to manage the flow of blood and also help the doctors and another healthcare professional to monitor the patients for various disorders such as COPD (Chronic Obstructive Pulmonary Disease), hypertension, and other problem, non-invasive pulse wave tonometer is used mainly consider for the heart-related problem. Nowadays most treatment centers are using these devices.

Non-invasive pulse wave tonometer is mostly used for monitoring blood flow and understanding the various diseases, to provide treatment. Various innovations are going on for developing the product to provide real-time monitoring of flow and provide treatment. The increasing number of patients and technological enhancement is the major potential for the non-invasive pulse wave tonometer market. The overall demand for non-invasive pulse wave tonometers is projected to grow at a CAGR of 5.8% between 2022 and 2032, totaling around US$ 194 Million by 2032.

Which Drivers Underpin Non-invasive Pulse Wave Tonometer Industry Expansion?

Increased Product Innovation Likely to Augment Non-invasive Pulse Wave Tonometer Sales

Non-invasive pulse wave tonometer is a growing market over the forecast period, as the number of patients is increasing related to heart, hypertension, and others. According to the British Lung Foundation, approx. 1.2 million people are suffering from COPD. The number of patients who are suffering from heart-related problems is also increasing in every region of the world.

The players are also coming up with new product innovations to make the product portable and provide in-depth monitoring of blood flow. The major strength of the system is that it can monitor the flow of blood non-invasive, while in the traditional case, the catheter was inserted to monitor the flow.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors are limiting the Growth of the Non-invasive Pulse Wave Tonometer Market?

High Rates of Investment to Impede the Growth

Although Non-invasive Pulse Wave Tonometer offers good ROI in the long run, the high initial investment is a deterrent for many organizations.

The high cost along with awareness and viability of the product the hinderers of the non-invasive pulse wave tonometer market.

Region-wise Insights

Will North America Continue Dominance in the Global Non-invasive Pulse Wave Tonometer Market?

Rising Market Competition to Boost the Market Growth in North America

The North American non-invasive pulse wave tonometer market is expected to accumulate a market share of 33.7% in 2022. North America is dominating and contributing the leading shares to the non-invasive pulse wave tonometer market in terms of revenue and is expected to register significant growth over a forecast period due to the increasing market competition.

The rising prevalence of glaucoma in the region is also adding to the market growth. According to the American Academy of Ophthalmology (AAO), glaucoma affects over 2.7 million of the population aged 40 and older in the USA

How big is the Non-invasive Pulse Wave Tonometer Market in Europe?

Rising Prevalence of Glaucoma Risk Factors to Boost Market Growth in Europe

The European region is anticipated to hold a market share of 30.8%. According to the WHO, there are over 60 million people living with diabetes in the European region. This is mainly due to rising behavioral risk factors such as smoking, alcohol consumption, unhealthy food habits, and a sedentary lifestyle.

Europe is expected to contribute to moderate revenue market share and register a healthy growth rate in the global Non-invasive Pulse Wave Tonometer market due to the rising prevalence of glaucoma risk factors such as diabetes, myopia, and hypertension in the region.

Start-ups for Non-invasive Pulse Wave Tonometer Market

Some key start-ups in the Non-invasive Pulse Wave Tonometer market include:

Tucson medical start-up CATS Tonometer won federal clearance to market a disposable version of its device to measure internal eye pressure, with plans to start selling the instrument this fall. The USA Food and Drug Administration approved CATS Tonometer’s disposable version of a prism device that increases the accuracy of a common instrument that measures eye pressure to diagnose diseases such as glaucoma. The company, founded in 2015 by the University of Arizona alumni Dr. Sean McCafferty, won FDA clearance for a reusable version of its patented prism in 2018. Market clearance is a form of FDA market approval mainly based on a medical device’s similarity to an already-approved device
iCare HOME2 provides unsurpassed ease of use and accuracy in monitoring real-world intraocular pressure behavior outside of the doctor’s office and clinical hours, supporting glaucoma management. Glaucoma is a chronic, progressive disease of the optic nerve. As intraocular pressure (IOP) is the only modifiable risk factor for glaucoma progression, disease management is centered on reducing IOP. Most patients can utilize iCare HOME2 simply by following the advice and guidance in the instruction materials, freeing up healthcare professionals’ precious time. iCare HOME2’s smart light guide helps the patient position the device correctly and make the measurements effortlessly and accurately, every time.

Who are the Leading Players in the Non-invasive Pulse Wave Tonometer Market?

Prominent players in the Non-invasive Pulse Wave Tonometer market are ADInstruments, Millar, DiaTecne s.r.l. and AtCor Medical Pty Ltd., and various other regional players.

In March 2021, iCare launched a digitally-driven tonometer, iCare Home 2, for patient home use, which has a fully integrated app for IOS and android and utilizes the cloud for data security and storage. It allows patients to self-measure their IOP (intraocular pressure) without the need to come to a clinic or hospital.
In February 2021, Reichert Technologies, a business unit of AMETEK Inc., launched Tono-Vera Vet Tonometer with ActiView Positioning System. It utilizes rebound tonometer technology, which eliminates the need for a topical anesthetic.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 5.8% from 2022 to 2032
Market Value in 2022	US$ 104.3 Million
Market Value in 2032	US$ 194 Million
Base Year for Estimation	2021
Historical Data	2016 to 2021
Forecast Period	2022 to 2032
Quantitative Units	Revenue in US$ Million and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	End-User Indication Region
Regions Covered	North America Latin America Europe South Asia East Asia Oceania Middle East and Africa (MEA)
Key Countries Profiled	The USA Canada Brazil Mexico Germany The United Kingdom France Spain Italy India Malaysia Singapore Thailand China Japan South Korea Australia New Zealand GCC South Africa Israel
Key Companies Profiled	ADInstruments Millar DiaTecne s.r.l AtCor Medical Pty. Ltd. Haag Streit AG Ametek Industries Technology Ray Vision International Corporation Crystalvue Medical Shanghai Vowish Optical Co. Ltd.
Customization	Available upon Request

Key Segments Covered in the Non-invasive Pulse Wave Tonometer Industry Analysis

Non-invasive Pulse Wave Tonometer Market by End User:

Non-invasive Pulse Wave Tonometers for Hospitals
Non-invasive Pulse Wave Tonometers for Clinics
Non-invasive Pulse Wave Tonometers for Other End Users

Non-invasive Pulse Wave Tonometer Market by Indication:

Non-invasive Pulse Wave Tonometers for Hypertension
Non-invasive Pulse Wave Tonometers for Renal Disease
Non-invasive Pulse Wave Tonometers for COPD
Non-invasive Pulse Wave Tonometers for Diabetes
Non-invasive Pulse Wave Tonometers for Heart Failure
Non-invasive Pulse Wave Tonometers for Other Disease Indications

Non-invasive Pulse Wave Tonometer Market by Region:

North America Non-invasive Pulse Wave Tonometer Market
Latin America Non-invasive Pulse Wave Tonometer Market
Europe Non-invasive Pulse Wave Tonometer Market
South Asia Non-invasive Pulse Wave Tonometer Market
East Asia Non-invasive Pulse Wave Tonometer Market
Oceania Non-invasive Pulse Wave Tonometer Market
Middle East and Africa (MEA) Non-invasive Pulse Wave Tonometer Market

Frequently Asked Questions

What is the expected market value for Non-invasive Pulse Wave Tonometer in 2022?

As of 2022, the Non-invasive Pulse Wave Tonometer market is slated to reach a valuation of US$ 104.3 Million

At what rate will the Non-invasive Pulse Wave Tonometer market flourish from 2022 to 2032?

From 2022 to 2032, sales of Non-invasive Pulse Wave Tonometer is expected to grow at a 5.8% CAGR

What is the expected market value for Non-invasive Pulse Wave Tonometer in 2032?

By 2032, Future Market Insights expects the Non-invasive Pulse Wave Tonometer market to reach US$ 194 Million.

Table of Content

1. Executive Summary | Non-invasive Pulse Wave Tonometer Market

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Analysis 2016 to 2021 and Forecast, 2022 to 2032

4.1. Historical Market Size Value (US$ million) Analysis, 2016 to 2021

4.2. Current and Future Market Size Value (US$ million) Projections, 2022 to 2032

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By Indication

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ million) Analysis By Indication, 2016 to 2021

5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Indication, 2022 to 2032

5.3.1. Hypertension

5.3.2. Renal Disease

5.3.3. COPD

5.3.4. Diabetes

5.3.5. Heart Failure

5.3.6. Others

5.4. Y-o-Y Growth Trend Analysis By Indication, 2016 to 2021

5.5. Absolute $ Opportunity Analysis By Indication, 2022 to 2032

6. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ million) Analysis By End User, 2016 to 2021

6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2022 to 2032

6.3.1. Hospitals

6.3.2. Clinics

6.3.3. Others

6.4. Y-o-Y Growth Trend Analysis By End User, 2016 to 2021

6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032

7. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region

7.1. Introduction

7.2. Historical Market Size Value (US$ million) Analysis By Region, 2016 to 2021

7.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2022 to 2032

7.3.1. North America

7.3.2. Latin America

7.3.3. Europe

7.3.4. South Asia

7.3.5. East Asia

7.3.6. Oceania

7.3.7. MEA

7.4. Market Attractiveness Analysis By Region

8. North America Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

8.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

8.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

8.2.1. By Country

8.2.1.1. The USA

8.2.1.2. Canada

8.2.2. By Indication

8.2.3. By End User

8.3. Market Attractiveness Analysis

8.3.1. By Country

8.3.2. By Indication

8.3.3. By End User

8.4. Key Takeaways

9. Latin America Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

9.2.1. By Country

9.2.1.1. Brazil

9.2.1.2. Mexico

9.2.1.3. Rest of Latin America

9.2.2. By Indication

9.2.3. By End User

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Indication

9.3.3. By End User

9.4. Key Takeaways

10. Europe Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

10.2.1. By Country

10.2.1.1. Germany

10.2.1.2. The United Kingdom

10.2.1.3. France

10.2.1.4. Spain

10.2.1.5. Italy

10.2.1.6. Rest of Europe

10.2.2. By Indication

10.2.3. By End User

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Indication

10.3.3. By End User

10.4. Key Takeaways

11. South Asia Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

11.2.1. By Country

11.2.1.1. India

11.2.1.2. Malaysia

11.2.1.3. Singapore

11.2.1.4. Thailand

11.2.1.5. Rest of South Asia

11.2.2. By Indication

11.2.3. By End User

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Indication

11.3.3. By End User

11.4. Key Takeaways

12. East Asia Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

12.2.1. By Country

12.2.1.1. China

12.2.1.2. Japan

12.2.1.3. South Korea

12.2.2. By Indication

12.2.3. By End User

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Indication

12.3.3. By End User

12.4. Key Takeaways

13. Oceania Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

13.2.1. By Country

13.2.1.1. Australia

13.2.1.2. New Zealand

13.2.2. By Indication

13.2.3. By End User

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Indication

13.3.3. By End User

13.4. Key Takeaways

14. MEA Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country

14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021

14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032

14.2.1. By Country

14.2.1.1. GCC Countries

14.2.1.2. South Africa

14.2.1.3. Israel

14.2.1.4. Rest of MEA

14.2.2. By Indication

14.2.3. By End User

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Indication

14.3.3. By End User

14.4. Key Takeaways

15. Key Countries Analysis

15.1. The USA

15.1.1. Pricing Analysis

15.1.2. Market Share Analysis, 2021

15.1.2.1. By Indication

15.1.2.2. By End User

15.2. Canada

15.2.1. Pricing Analysis

15.2.2. Market Share Analysis, 2021

15.2.2.1. By Indication

15.2.2.2. By End User

15.3. Brazil

15.3.1. Pricing Analysis

15.3.2. Market Share Analysis, 2021

15.3.2.1. By Indication

15.3.2.2. By End User

15.4. Mexico

15.4.1. Pricing Analysis

15.4.2. Market Share Analysis, 2021

15.4.2.1. By Indication

15.4.2.2. By End User

15.5. Germany

15.5.1. Pricing Analysis

15.5.2. Market Share Analysis, 2021

15.5.2.1. By Indication

15.5.2.2. By End User

15.6. The United Kingdom

15.6.1. Pricing Analysis

15.6.2. Market Share Analysis, 2021

15.6.2.1. By Indication

15.6.2.2. By End User

15.7. France

15.7.1. Pricing Analysis

15.7.2. Market Share Analysis, 2021

15.7.2.1. By Indication

15.7.2.2. By End User

15.8. Spain

15.8.1. Pricing Analysis

15.8.2. Market Share Analysis, 2021

15.8.2.1. By Indication

15.8.2.2. By End User

15.9. Italy

15.9.1. Pricing Analysis

15.9.2. Market Share Analysis, 2021

15.9.2.1. By Indication

15.9.2.2. By End User

15.10. India

15.10.1. Pricing Analysis

15.10.2. Market Share Analysis, 2021

15.10.2.1. By Indication

15.10.2.2. By End User

15.11. Malaysia

15.11.1. Pricing Analysis

15.11.2. Market Share Analysis, 2021

15.11.2.1. By Indication

15.11.2.2. By End User

15.12. Singapore

15.12.1. Pricing Analysis

15.12.2. Market Share Analysis, 2021

15.12.2.1. By Indication

15.12.2.2. By End User

15.13. Thailand

15.13.1. Pricing Analysis

15.13.2. Market Share Analysis, 2021

15.13.2.1. By Indication

15.13.2.2. By End User

15.14. China

15.14.1. Pricing Analysis

15.14.2. Market Share Analysis, 2021

15.14.2.1. By Indication

15.14.2.2. By End User

15.15. Japan

15.15.1. Pricing Analysis

15.15.2. Market Share Analysis, 2021

15.15.2.1. By Indication

15.15.2.2. By End User

15.16. South Korea

15.16.1. Pricing Analysis

15.16.2. Market Share Analysis, 2021

15.16.2.1. By Indication

15.16.2.2. By End User

15.17. Australia

15.17.1. Pricing Analysis

15.17.2. Market Share Analysis, 2021

15.17.2.1. By Indication

15.17.2.2. By End User

15.18. New Zealand

15.18.1. Pricing Analysis

15.18.2. Market Share Analysis, 2021

15.18.2.1. By Indication

15.18.2.2. By End User

15.19. GCC Countries

15.19.1. Pricing Analysis

15.19.2. Market Share Analysis, 2021

15.19.2.1. By Indication

15.19.2.2. By End User

15.20. South Africa

15.20.1. Pricing Analysis

15.20.2. Market Share Analysis, 2021

15.20.2.1. By Indication

15.20.2.2. By End User

15.21. Israel

15.21.1. Pricing Analysis

15.21.2. Market Share Analysis, 2021

15.21.2.1. By Indication

15.21.2.2. By End User

16. Market Structure Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Market Share Analysis of Top Players

16.3.1. By Regional

16.3.2. By Indication

16.3.3. By End User

17. Competition Analysis

17.1. Competition Deep Dive

17.1.1. ADInstruments

17.1.1.1. Overview

17.1.1.2. Product Portfolio

17.1.1.3. Profitability by Market Segments

17.1.1.4. Sales Footprint

17.1.1.5. Strategy Overview

17.1.1.5.1. Marketing Strategy

17.1.2. Millar

17.1.2.1. Overview

17.1.2.2. Product Portfolio

17.1.2.3. Profitability by Market Segments

17.1.2.4. Sales Footprint

17.1.2.5. Strategy Overview

17.1.2.5.1. Marketing Strategy

17.1.3. DiaTecne s.r.l.

17.1.3.1. Overview

17.1.3.2. Product Portfolio

17.1.3.3. Profitability by Market Segments

17.1.3.4. Sales Footprint

17.1.3.5. Strategy Overview

17.1.3.5.1. Marketing Strategy

17.1.4. AtCor Medical Pty Ltd.

17.1.4.1. Overview

17.1.4.2. Product Portfolio

17.1.4.3. Profitability by Market Segments

17.1.4.4. Sales Footprint

17.1.4.5. Strategy Overview

17.1.4.5.1. Marketing Strategy

17.1.5. Haag Streit AG

17.1.5.1. Overview

17.1.5.2. Product Portfolio

17.1.5.3. Profitability by Market Segments

17.1.5.4. Sales Footprint

17.1.5.5. Strategy Overview

17.1.5.5.1. Marketing Strategy

17.1.6. Ametek Industries Technology

17.1.6.1. Overview

17.1.6.2. Product Portfolio

17.1.6.3. Profitability by Market Segments

17.1.6.4. Sales Footprint

17.1.6.5. Strategy Overview

17.1.6.5.1. Marketing Strategy

17.1.7. Ray Vision International Corporation

17.1.7.1. Overview

17.1.7.2. Product Portfolio

17.1.7.3. Profitability by Market Segments

17.1.7.4. Sales Footprint

17.1.7.5. Strategy Overview

17.1.7.5.1. Marketing Strategy

17.1.8. Crystalvue Medical

17.1.8.1. Overview

17.1.8.2. Product Portfolio

17.1.8.3. Profitability by Market Segments

17.1.8.4. Sales Footprint

17.1.8.5. Strategy Overview

17.1.8.5.1. Marketing Strategy

17.1.9. Shanghai Vowish Optical Co., Ltd.

17.1.9.1. Overview

17.1.9.2. Product Portfolio

17.1.9.3. Profitability by Market Segments

17.1.9.4. Sales Footprint

17.1.9.5. Strategy Overview

17.1.9.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Non-invasive Pulse Wave Tonometer Market

Non-invasive Pulse Wave Tonometer Market by Indication, End User & Region | Forecast 2022 to 2032